330 related articles for article (PubMed ID: 9682282)
1. Modification of cataleptic responses to dopamine receptor antagonists after withdrawal from chronic cocaine or cocaine plus dopamine antagonist administration.
Ushijima I; Mizuki Y; Suetsugi M; Akimoto T; Yamada M
Prog Neuropsychopharmacol Biol Psychiatry; 1998 May; 22(4):709-21. PubMed ID: 9682282
[TBL] [Abstract][Full Text] [Related]
2. Effects of pertussis toxin on behavioral responses during different withdrawal periods from chronic cocaine treatment.
Ushijima I; Mizuki Y; Kobayashi T; Aoki T; Suetsugi M; Usami K; Watanabe Y
Prog Neuropsychopharmacol Biol Psychiatry; 2000 Nov; 24(8):1369-77. PubMed ID: 11125860
[TBL] [Abstract][Full Text] [Related]
3. Alteration of cataleptic responses induced by dopamine receptor antagonists after chronic cocaine administration in mice.
Ushijima I; Mizuki Y; Yamada M
Eur J Pharmacol; 1995 Oct; 285(1):55-9. PubMed ID: 8846811
[TBL] [Abstract][Full Text] [Related]
4. Effects of chronic methamphetamine on SCH23390- or haloperidol-induced catalepsy, and effects of coadministration of SCH23390 or haloperidol in mice.
Mizuki Y; Ushijima I; Yamada M
Pharmacol Biochem Behav; 1996 Feb; 53(2):437-40. PubMed ID: 8808155
[TBL] [Abstract][Full Text] [Related]
5. Development of tolerance and reverse tolerance to haloperidol- and SCH23390-induced cataleptic effects during withdrawal periods after long-term treatment.
Ushijima I; Mizuki Y; Yamada M
Pharmacol Biochem Behav; 1995 Feb; 50(2):259-64. PubMed ID: 7740066
[TBL] [Abstract][Full Text] [Related]
6. Dopaminergic and cholinergic interaction in cataleptic responses in mice.
Ushijima I; Kawano M; Kaneyuki H; Suetsugi M; Usami K; Hirano H; Mizuki Y; Yamada M
Pharmacol Biochem Behav; 1997 Sep; 58(1):103-8. PubMed ID: 9264077
[TBL] [Abstract][Full Text] [Related]
7. Prediction of drug-induced catalepsy based on dopamine D1, D2, and muscarinic acetylcholine receptor occupancies.
Haraguchi K; Ito K; Kotaki H; Sawada Y; Iga T
Drug Metab Dispos; 1997 Jun; 25(6):675-84. PubMed ID: 9193868
[TBL] [Abstract][Full Text] [Related]
8. Involvement of D1 and D2 dopamine systems in the behavioral effects of cocaine in rats.
Ushijima I; Carino MA; Horita A
Pharmacol Biochem Behav; 1995 Dec; 52(4):737-41. PubMed ID: 8587913
[TBL] [Abstract][Full Text] [Related]
9. Addiction-related alterations in D1 and D2 dopamine receptor behavioral responses following chronic cocaine self-administration.
Edwards S; Whisler KN; Fuller DC; Orsulak PJ; Self DW
Neuropsychopharmacology; 2007 Feb; 32(2):354-66. PubMed ID: 16541082
[TBL] [Abstract][Full Text] [Related]
10. Effects of chronic SCH23390 treatment on the biochemical and behavioral properties of D1 and D2 dopamine receptors: potentiated behavioral responses to a D2 dopamine agonist after selective D1 dopamine receptor upregulation.
Hess EJ; Albers LJ; Le H; Creese I
J Pharmacol Exp Ther; 1986 Sep; 238(3):846-54. PubMed ID: 3018223
[TBL] [Abstract][Full Text] [Related]
11. D2 dopamine antisense RNA expression vector, unlike haloperidol, produces long-term inhibition of D2 dopamine-mediated behaviors without causing Up-regulation of D2 dopamine receptors.
Davidkova G; Zhou LW; Morabito M; Zhang SP; Weiss B
J Pharmacol Exp Ther; 1998 Jun; 285(3):1187-96. PubMed ID: 9618422
[TBL] [Abstract][Full Text] [Related]
12. Contribution of the central histaminergic transmission in the cataleptic and neuroleptic effects of haloperidol.
Jain NS; Tandi L; Verma L
Pharmacol Biochem Behav; 2015 Dec; 139(Pt A):59-66. PubMed ID: 26455279
[TBL] [Abstract][Full Text] [Related]
13. D1 and D2 dopamine receptor-mediated mechanisms and behavioral supersensitivity.
Marin C; Parashos SA; Kapitzoglou-Logothetis V; Peppe A; Chase TN
Pharmacol Biochem Behav; 1993 May; 45(1):195-200. PubMed ID: 8516358
[TBL] [Abstract][Full Text] [Related]
14. NMDA receptor antagonists inhibit catalepsy induced by either dopamine D1 or D2 receptor antagonists.
Moore NA; Blackman A; Awere S; Leander JD
Eur J Pharmacol; 1993 Jun; 237(1):1-7. PubMed ID: 8359205
[TBL] [Abstract][Full Text] [Related]
15. Importance of D1 and D2 receptor stimulation for the induction and expression of cocaine-induced behavioral sensitization in preweanling rats.
McDougall SA; Rudberg KN; Veliz A; Dhargalkar JM; Garcia AS; Romero LC; Gonzalez AE; Mohd-Yusof A; Crawford CA
Behav Brain Res; 2017 May; 326():226-236. PubMed ID: 28284952
[TBL] [Abstract][Full Text] [Related]
16. Differential influence of D1 and D2 dopamine receptors on acute opiate withdrawal in guinea-pig isolated ileum.
Capasso A; Sorrentino L
Br J Pharmacol; 1997 Mar; 120(6):1001-6. PubMed ID: 9134209
[TBL] [Abstract][Full Text] [Related]
17. Haloperidol-induced catalepsy is absent in dopamine D(2), but maintained in dopamine D(3) receptor knock-out mice.
Boulay D; Depoortere R; Oblin A; Sanger DJ; Schoemaker H; Perrault G
Eur J Pharmacol; 2000 Mar; 391(1-2):63-73. PubMed ID: 10720636
[TBL] [Abstract][Full Text] [Related]
18. Cocaine: evidence for NMDA-, beta-carboline- and dopaminergic-mediated seizures in mice.
Ushijima I; Kobayashi T; Suetsugi M; Watanabe K; Yamada M; Yamaguchi K
Brain Res; 1998 Jun; 797(2):347-50. PubMed ID: 9666168
[TBL] [Abstract][Full Text] [Related]
19. Comparison of dopamine receptor antagonists on hyperlocomotion induced by cocaine, amphetamine, MK-801 and the dopamine D1 agonist C-APB in mice.
O'Neill MF; Shaw G
Psychopharmacology (Berl); 1999 Aug; 145(3):237-50. PubMed ID: 10494572
[TBL] [Abstract][Full Text] [Related]
20. D1/D2 dopamine and N-methyl-D-aspartate (NMDA) receptor participation in experimental catalepsy in rats.
Verma A; Kulkarni SK
Psychopharmacology (Berl); 1992; 109(4):477-83. PubMed ID: 1365866
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
